Whilst the Newcastle and Manchester-derived AD groups and Auckland-derived HD group did not differ significantly across any of the comparable variables from the PDD controls, the Auckland-derived AD group showed significantly lower age, tau Braak staging, and age than the PDD controls. The gene discussed is MAPT; the disease is Alzheimer disease.